Iris A. L. Silva

927 total citations
38 papers, 562 citations indexed

About

Iris A. L. Silva is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Iris A. L. Silva has authored 38 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Iris A. L. Silva's work include Cystic Fibrosis Research Advances (25 papers), Neonatal Respiratory Health Research (16 papers) and Asthma and respiratory diseases (5 papers). Iris A. L. Silva is often cited by papers focused on Cystic Fibrosis Research Advances (25 papers), Neonatal Respiratory Health Research (16 papers) and Asthma and respiratory diseases (5 papers). Iris A. L. Silva collaborates with scholars based in Portugal, Germany and Netherlands. Iris A. L. Silva's co-authors include Margarida D. Amaral, M. Leonor Cancela, Miquéias Lopes‐Pacheco, Madalena C. Pinto, Luka A. Clarke, Jeffrey M. Beekman, Natércia Conceição, Annelotte M. Vonk, Carlos M. Farinha and Vânia Palma Roberto and has published in prestigious journals such as Bioinformatics, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Iris A. L. Silva

35 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris A. L. Silva Portugal 14 375 202 55 52 43 38 562
Abinaya Nathan United States 8 127 0.3× 271 1.3× 15 0.3× 46 0.9× 33 0.8× 10 538
John Snowball United States 13 232 0.6× 194 1.0× 30 0.5× 36 0.7× 39 0.9× 24 451
Venkateshwar Mutyam United States 10 300 0.8× 333 1.6× 37 0.7× 67 1.3× 6 0.1× 14 583
Sumati Ram‐Mohan United States 12 129 0.3× 99 0.5× 78 1.4× 16 0.3× 24 0.6× 15 319
Rupesh Nigam United States 6 168 0.4× 121 0.6× 103 1.9× 34 0.7× 14 0.3× 7 369
Emi Aizawa Japan 11 103 0.3× 529 2.6× 33 0.6× 161 3.1× 13 0.3× 21 657
Chisa Matsuoka Japan 8 99 0.3× 652 3.2× 20 0.4× 164 3.2× 45 1.0× 9 752
Jianbo Lin China 14 126 0.3× 187 0.9× 74 1.3× 18 0.3× 126 2.9× 50 538
Kewu Jiang China 6 241 0.6× 170 0.8× 25 0.5× 12 0.2× 15 0.3× 7 460

Countries citing papers authored by Iris A. L. Silva

Since Specialization
Citations

This map shows the geographic impact of Iris A. L. Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris A. L. Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris A. L. Silva more than expected).

Fields of papers citing papers by Iris A. L. Silva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris A. L. Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris A. L. Silva. The network helps show where Iris A. L. Silva may publish in the future.

Co-authorship network of co-authors of Iris A. L. Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Iris A. L. Silva. A scholar is included among the top collaborators of Iris A. L. Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris A. L. Silva. Iris A. L. Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Pereira, Ana L., et al.. (2025). N1303K (p.Asn1303Lys) variant: Expanding frontiers in the treatment of cystic fibrosis. Respiratory Medicine. 246. 108238–108238. 1 indexed citations
4.
Ramalho, Anabela S., Iris A. L. Silva, Annelotte M. Vonk, et al.. (2024). Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic Fibrosis. Journal of Cystic Fibrosis. 23(4). 693–702. 10 indexed citations
5.
Silva, Iris A. L., Florbela Soares, Pedro Pousão‐Ferreira, et al.. (2024). Eco-innovative aquafeeds biofortified with Asparagopsis taxiformis to improve the resilience of farmed white seabream (Diplodus sargus) to marine heatwave events. Heliyon. 10(15). e35135–e35135. 2 indexed citations
6.
Silva, Iris A. L., et al.. (2023). Personalized medicine: Function of CFTR variant p.Arg334Trp is rescued by currently available CFTR modulators. Frontiers in Molecular Biosciences. 10. 1155705–1155705. 7 indexed citations
7.
Silva, Iris A. L., et al.. (2023). Additive Potentiation of R334W-CFTR Function by Novel Small Molecules. Journal of Personalized Medicine. 13(1). 102–102. 9 indexed citations
8.
Silva, Iris A. L., et al.. (2022). New drugs in cystic fibrosis: what has changed in the last decade?. Therapeutic Advances in Chronic Disease. 13. 374146712–374146712. 5 indexed citations
9.
Pinto, Madalena C., et al.. (2021). Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis. Journal of Experimental Pharmacology. Volume 13. 693–723. 37 indexed citations
10.
Silva, Iris A. L., et al.. (2021). Pediatric population with cystic fibrosis in the centre of Portugal: candidates for new therapies. Jornal de Pediatria. 98(2). 212–217.
11.
Pinto, Madalena C., et al.. (2021). Synergy in Cystic Fibrosis Therapies: Targeting SLC26A9. International Journal of Molecular Sciences. 22(23). 13064–13064. 12 indexed citations
12.
Silva, Iris A. L., Luka A. Clarke, Hugo M. Botelho, et al.. (2020). Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A>G. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(11). 165905–165905. 12 indexed citations
13.
Lopes‐Pacheco, Miquéias, Iris A. L. Silva, Graeme W. Carlile, et al.. (2020). Characterization of the mechanism of action of RDR01752, a novel corrector of F508del-CFTR. Biochemical Pharmacology. 180. 114133–114133. 15 indexed citations
14.
Clarke, Luka A., et al.. (2019). TMEM16A chloride channel does not drive mucus production. Life Science Alliance. 2(6). e201900462–e201900462. 29 indexed citations
15.
Silva, Iris A. L., Natércia Conceição, Édith Gagnon, et al.. (2018). Molecular effect of an OPTN common variant associated to Paget's disease of bone. PLoS ONE. 13(5). e0197543–e0197543. 10 indexed citations
16.
Silva, Iris A. L., Natércia Conceição, Édith Gagnon, et al.. (2017). Effect of genetic variants of OPTN in the pathophysiology of Paget's disease of bone. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(1). 143–151. 17 indexed citations
17.
Silva, Iris A. L. & Natércia Conceição. (2015). Cloning, characterization and analysis of the 5′ regulatory region of zebrafish xpd gene. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 185. 47–53. 2 indexed citations
18.
Silva, Iris A. L., Cymon J. Cox, Ricardo B. Leite, M. Leonor Cancela, & Natércia Conceição. (2014). Evolutionary conservation of TFIIH subunits: Implications for the use of zebrafish as a model to study TFIIH function and regulation. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 172-173. 9–20. 1 indexed citations
19.
Sen, Partha, Petr Janků, Marta Ježová, et al.. (2012). A familial case of alveolar capillary dysplasia with misalignment of pulmonary veins supports paternal imprinting of FOXF1 in human. European Journal of Human Genetics. 21(4). 474–477. 34 indexed citations
20.
Silva, Iris A. L., M. Leonor Cancela, & Natércia Conceição. (2011). Molecular cloning and expression analysis of xpd from zebrafish (Danio rerio). Molecular Biology Reports. 39(5). 5339–5348. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abinaya Nathan Breakdown of academic impact, for papers by John Snowball Breakdown of academic impact, for papers by Venkateshwar Mutyam Breakdown of academic impact, for papers by Sumati Ram‐Mohan Breakdown of academic impact, for papers by Rupesh Nigam Breakdown of academic impact, for papers by Emi Aizawa Breakdown of academic impact, for papers by Chisa Matsuoka Breakdown of academic impact, for papers by Jianbo Lin Breakdown of academic impact, for papers by Kewu Jiang
Rankless by CCL
2026